ELELYSO

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0069-0106
  • Package NDC 0069-0106-01
  • Application number BLA022458
  • SPL ID d7eb51c8-fe18-46f2-8d97-eaa343ec8821
  • SPL set ID fa3cbd5d-677c-4b19-9032-d9182cb69a83
  • UNII 0R4NLX88O4
  • RxCUI 1292879
  • RxCUI 1292881

What the source publishes

Labeler
Pfizer Laboratories Div Pfizer Inc
Active ingredients
Taliglucerase alfa
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821
{
  "name": "ELELYSO",
  "splId": "d7eb51c8-fe18-46f2-8d97-eaa343ec8821",
  "labels": [
    {
      "setId": "fa3cbd5d-677c-4b19-9032-d9182cb69a83",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa3cbd5d-677c-4b19-9032-d9182cb69a83",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fa3cbd5d-677c-4b19-9032-d9182cb69a83"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Pfizer Laboratories Div Pfizer Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, GLASS in 1 CARTON (0069-0106-01)  / 5 mL in 1 VIAL, GLASS",
      "package_ndc": "0069-0106-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20120501"
    }
  ],
  "productId": "0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "0069-0106",
  "deaSchedule": null,
  "genericName": "Taliglucerase alfa",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TALIGLUCERASE ALFA",
      "strength": "200 U/5mL"
    }
  ],
  "applicationNumber": "BLA022458",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20120501",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175820",
      "M0009360"
    ],
    "unii": [
      "0R4NLX88O4"
    ],
    "rxcui": [
      "1292879",
      "1292881"
    ],
    "spl_set_id": [
      "fa3cbd5d-677c-4b19-9032-d9182cb69a83"
    ],
    "pharm_class_cs": [
      "Glucosylceramidase [CS]"
    ],
    "pharm_class_epc": [
      "Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"
    ],
    "manufacturer_name": [
      "Pfizer Laboratories Div Pfizer Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821"